# FDA Inspection 1190814 - Biomat USA, Inc - November 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c41cc0f6-50ec-4021-a06a-2d150e75b956
Source feed: FDA_Inspections

> FDA Inspection 1190814 for Biomat USA, Inc on November 17, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1190814
- Company Name: Biomat USA, Inc
- Inspection Date: 2022-11-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1190814 - 2022-11-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3cd0b338-8fbf-4431-9d43-9353e0f04833)

Company: https://www.keypedia.com/companies/biomat-usa-inc/dbfd5ff4-bfba-417e-95e7-970a45d5743b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d